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Abstract
Background: Leishmania is transmitted by female sand flies and deposited together with saliva, which contains a vast
repertoire of pharmacologically active molecules that contribute to the establishment of the infection. The exposure to
vector saliva induces an immune response against its components that can be used as a marker of exposure to the vector.
Performing large-scale serological studies to detect vector exposure has been limited by the difficulty in obtaining sand fly
saliva. Here, we validate the use of two sand fly salivary recombinant proteins as markers for vector exposure.
Methodology/principal findings: ELISA was used to screen human sera, collected in an area endemic for visceral
leishmaniasis, against the salivary gland sonicate (SGS) or two recombinant proteins (rLJM11 and rLJM17) from Lutzomyia
longipalpis saliva. Antibody levels before and after SGS seroconversion (n=26) were compared using the Wilcoxon signed
rank paired test. Human sera from an area endemic for VL which recognize Lu. longipalpis saliva in ELISA also recognize a
combination of rLJM17 and rLJM11. We then extended the analysis to include 40 sera from individuals who were seropositive
and 40 seronegative to Lu. longipalpis SGS. Each recombinant protein was able to detect anti-saliva seroconversion, whereas
the two proteins combined increased the detection significantly. Additionally, we evaluated the specificity of the anti-Lu.
longipalpis response by testing 40 sera positive to Lutzomyia intermedia SGS, and very limited (2/40) cross-reactivity was
observed. Receiver-operator characteristics (ROC) curve analysis was used to identify the effectiveness of these proteins for
the prediction of anti-SGS positivity. These ROC curves evidenced the superior performance of rLJM17+rLJM11. Predicted
threshold levels were confirmed for rLJM17+rLJM11 using a large panel of 1,077 serum samples.
Conclusion: Our results show the possibility of substituting Lu. longipalpis SGS for two recombinant proteins, LJM17 and
LJM11, in order to probe for vector exposure in individuals residing in endemic areas.
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Introduction
The Leishmaniasis is a widely distributed disease, caused by
Leishmania protozoans and transmitted by sand fly vectors. Infected
sand flies inject parasites when attempting to take a blood meal. In
this process, vector saliva is inoculated together with Leishmania
into the host skin. This saliva is composed of molecules that
modulate the host’s hemostatic, inflammatory and immune
responses [1]. Some of these molecules are immunogenic and
stimulate strong immune responses in animals including humans
[2,3]. Importantly, the humoral response against sand fly saliva
has been proposed as a potential epidemiological marker of vector
exposure in endemic areas of Leishmaniasis [4,5].
Sand fly populations tend to be clustered [5] leading to unequal
exposure of human populations. Screening of human antibodies to
sand fly saliva could be a useful indicator of the spatial distribution
of sand flies in a particular region. Pinpointing areas of high
exposure to sand fly bites may be helpful in directing control
measures against Leishmaniasis.
Large-scale serological studies to detect vector exposure have
been limited by the difficulty in obtaining large amounts of saliva.
Additionally, the use of salivary gland sonicate inherits the limitation
www.plosntds.org 1 March 2010 | Volume 4 | Issue 3 | e649of potentially considerable variability in stocks of sand fly saliva due
to differences in the feeding source and time of collection after
feeding [6]. Salivary protein content varies along the feeding cycle
a n di si n f l u e n c e db yt h es o u r c eo ff e e d i n gu s e db ys a n df l i e s[ 6 ] .
Another limitation of using SGS is a potential lack of specificity
of the salivary proteins due to immunogenicity of proteins present
in different species. The use recombinant proteins may reduce
such a problem by using proteins which exhibit predominant
species-specificity.
Two recombinant molecules, rLJM17 and rLJM11, from
Lutzomyia longipalpis saliva, were recognized by sera of men, dogs
and foxes from endemic areas for visceral Leishmaniasis (Teixeira
et al., unpublished data), represent good candidates for large scale
testing of human exposure to Lu. longipalpis bites. In this study, we
tested a large cohort for exposure to Lu. longipalpis, and validated




Informed consents were obtained from all participants and all
clinical investigations were conducted according to the principles
expressed in the Declaration of Helsinki. The project was
approved by the institutional review board from Centro de
Pesquisas Gonc ¸alo Moniz-FIOCRUZ/BA.
Sand Flies and Preparation of SGS
Lutzomyia longipalpis, Cavunge strain, were reared at Centro de
Pesquisas Gonc ¸alo Moniz-FIOCRUZ, as described elsewhere [7].
Salivary glands were stored in groups of 20 pairs in 20 mlN a C l
(150 mM) Hepes buffer (10 mM, pH 7.4), at 270uC. Immediately
before use, salivary glands were disrupted by ultrasonication. Tubes
were centrifuged at 10,0006g for 2 min and the resultant supernatant
(Salivary Gland Sonicate - SGS) was used for the studies.
Study Design and Participants
This study was divided in three phases (Figure 1). Different sets
of serum samples were randomly selected from three independent
epidemiological surveys previously performed in two endemic
areas for Leishmaniasis (one for VL and the other for cutaneous
Leishmaniasis). The selection criteria of the subjects enrolled in
each survey are published elsewhere [5,8,9]. In the first phase, 26
serum samples were obtained from an epidemiological survey of
VL in children less than 7 years old living in a region of Sa ˜o Luis,
Maranha ˜o State, in northeastern Brazil, where VL is endemic and
Lu. longipalpis is prevalent [5]. These samples were selected based
on presenting seroconversion against the Lu. longipalpis SGS after a
follow up period of six months. The cut off value of the anti-SGS
ELISA was established as the mean plus three standard deviations
(SD) of the mean optical density (OD) of serum samples of 26
individuals from an urban non-endemic area for both human
Leishmaniasis and Lu. longipalpis. Serum samples with OD above
this cut-off (0.073) were considered SGS-positive. The same
methodology was applied to assess the cut-off values for the
recombinant proteins. The objective was to primary set the cut-off
values and to verify the concordance of seroconversion against the
SGS and the recombinant proteins.
In the second part of the study, we attempted to check if the
recombinant proteins were useful to discriminate anti-SGS
positivity. To do this, we randomly selected another 80 individuals
from the same endemic area, 40 being positive and 40 being
negative for anti-SGS, and performed serology against the
recombinant proteins. Receiver-Operator Characteristic (ROC)
curves were built for each protein separately and for the
combination of both. New cut-offs combining highest sensitivity
and specificity and the highest likelihood ratio for this discrimi-
nation were determined based on the ROC curves. The ROC
curves lead us to identify the effectiveness of these proteins for the
identification of anti-SGS positivity.
In addition, to evaluate specificity regarding reactivity to other
sand flies, we used 40 serum samples obtained from an
epidemiological survey conducted in a region endemic for
American cutaneous Leishmaniasis (Canoa, a rural village, located
near Santo Amaro, Bahia, Brazil). In this region, Lu. intermedia
represents the major sand fly species, with L. braziliensis being the
main Leishmania species in the area. Both Lu. longipalpis and Lu.
intermedia normally live in different ecosystems and only rarely
individuals are exposed to both of them. Details of the area,
patients and anti-Leishmania delayed type hypersensitivity skin test
are described elsewhere [8]. We used data from 40 individuals
exposed to Lu. intermedia in a previous investigation [9] and
addressed the cross-reactivity to the whole SGS or the recombi-
nant salivary proteins from Lu. longipalpis.
The third part of the study was the validation of the serology
for detection of antibodies against the Lu. longipalpis salivary
recombinant proteins as a marker of vector exposure. We used a
larger panel consisting of 1,077 sera from another population
survey done through home visits. Therefore, serum samples were
obtained from children residing in two endemic areas for visceral
Leishmaniasis (Vila Nova and Bom Viver), in Raposa county,
Maranha ˜o State, Brazil. Vila Nova and Bom Viver have an
approximate population of 2,600 and 4,307 inhabitants,
respectively. Within this population, a total of 1,297 children
under 10 years old were identified and, of these, 1,077 children
were enrolled in the study (220 individuals withdrawn consent).
The flow chart of the third phase of the study is illustrated in
Figure S1.
Expression and HPLC Purification of His-tagged Lu.
longipalpis Salivary Proteins
Antibodies to sand fly saliva from endemic area humans, dogs,
or fox sera recognize mostly salivary proteins in the range of 15 to
Author Summary
During the blood meal, female sand flies (insects that
transmit the parasite Leishmania) inject saliva containing a
large variety of molecules with different pharmacological
activities that facilitate the acquisition of blood. These
molecules can induce the production of anti-saliva
antibodies, which can then be used as markers for insect
(vector) biting or exposure. Epidemiological studies using
sand fly salivary gland sonicate as antigens are hampered
by the difficulty of obtaining large amounts of salivary
glands. In the present study, we have investigated the use
of two salivary recombinant proteins from the sand fly
Lutzomyia longipalpis, considered the main vector of
visceral leishmaniasis, as an alternative method for
screening of exposure to the sand fly. We primarily tested
the suitability of using the recombinant proteins to
estimate positive anti-saliva ELISA test in small sets of
serum samples. Further, we validated the assay in a large
sample of 1,077 individuals from an epidemiological
survey in a second area endemic for visceral leishmaniasis.
Our findings indicate that these proteins represent a
promising epidemiological tool that can aid in implement-
ing control measures against leishmaniasis.
Epidemiological Markers of Sand Fly Exposure
www.plosntds.org 2 March 2010 | Volume 4 | Issue 3 | e64965 kDa. Based on this information we selected nine transcripts
coding for salivary proteins from Lu. longipalpis falling in this
molecular range (LJM17 [AF132518], LJM111 [DQ192488],
LJM11 [AY445935], LJL143 [AY445936], LJL13 [AF420274],
LJL23 [AF131933], LJM04 [AAD32197.1], LJL138 [AY455916],
and LJL11 [AF132510]) [10]. From the range of recombinat
salivary proteins tested rLJM17 and rLJM11 were the best
candidates recognized by sera from all three hosts (Teixeira et al.
unpublished data). Recombinant proteins were produced by
transfecting 293-F cells (Invitrogen) with plasmids (VR2001-
TOPO) coding for these different salivary proteins following the
manufacturer’s recommendations (Teixeira et al. unpublished
data). The concentrated supernatant was added to a HiTrap
chelating HP column (GE Healthcare) that was then connected to
a Summit station HPLC system (Dionex, Sunnyvale, CA)
consisting of a P680 HPLC pump and a PDA-100 detector.
Serology
ELISA was performed as described before [4]. Briefly, ELISA
plates were coated with Lu. longipalpis SGS, equivalent to 5 pairs
of salivary glands/mL (approximately 5 ug protein/mL), or with
1 ug of each recombinant protein/mL (when used indepen-
dently or in combination) in carbonate buffer (NaHCO3
0.45 M, Na2CO3 0.02 M, pH 9.6) overnight at 4uC. After
three washes with PBS- 0.05% Tween, the plates were blocked
for 1 hour at 37uC with PBS-0.1% Tween plus 0.05% BSA.
Sera were diluted 1:50 with PBS-0.05% Tween and incubated
o v e r n i g h ta t4 uc. After further washings, the wells were
incubated with alkaline-phosphatase-conjugated anti-human
IgG (Sigma, Sr. Louis, MO) at a 1:1,000 dilution for 45
minutes at 37uc. Following another washing cycle, the color was
developed for 30 minutes with a chromogenic solution of p-
nitrophenylphosphate in sodium carbonate buffer pH 9.6 with
lmg/mL of MgCI2.
The concentrations of saliva or recombinant proteins used
were determined in a dose- response experiment to assess the
optimum signal without loosing specificity. In all experiments,
values obtained were subtracted from those obtained the
background (i.e. OD values observed in well with only buffer
and without SGS or recombinant antigens). The serological
experiments were repeated twice with similar results. The
laboratory personnel who performed the assays using the
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Figure 1. Study flow chart. The study was divided in three phases, each of them using different sample sets to address the suitability for the use of
Lu. longipalpis salivary recombinant proteins as marker of human vector exposure. To establish the cut-off values form the first phase, 26 indiduals
from a non-endemic area were tested for SGS and the recombinant proteins (see details in the methods section). In the first and second phases,
samples were obtained from Sa ˜o Luis, Maranha ˜o State, in northeastern Brazil, where VL is endemic and Lu. longipalpis is prevalent. To assess cross-
reactivity, 40 samples from the VL endemic area who were positive for Lu. longipalpis anti-SGS were tested fom anti-SGS from Lu. intermedia, while
other 40 samples from an endemic area of cutaneous leishmaniasis were used (Canoas, a rural village in Bahia, Brazil) were tested for anti-SGS from
Lu. longipalpis and the recombinant proteins (dashed line box). The third phase used serum samples obtained from children residing in two other
endemic areas for visceral leishmaniasis (Vila Nova and Bom Viver), in Raposa county, Maranha ˜o State, Brazil. The study design details are described in
methods. SGS: salivary gland sonitate; VL: visceral leishmaniasis.
doi:10.1371/journal.pntd.0000649.g001
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www.plosntds.org 3 March 2010 | Volume 4 | Issue 3 | e649Figure 2. Recombinant Lu. longipalpis salivary proteins as a suitable marker of vector sand fly exposure. Sera from individuals
residing in a visceral leishmaniasis endemic area (n=26) were tested by ELISA against SGS, rLJM11, rLJM17 and rLJM11+rLJM17. A, anti-SGS
antiboby titers in individuals before and after anti-SGS seroconversion (cut-off value: 0.06). B, anti-LJM 11 antibody levels before and after
seroconversion against total SGS (cut-off: 0.067). C, anti-LJM 17 antibody levels before and after anti-SGS seroconversion (cut-off: 0.042). D,
antibody levels against rLJM11+rLJM 17 before and after anti-SGS seroconversion (cut-off: 0.038). E, for each individual, the magnitude of the
seroconversion was estimated by ratios between the antibody levels after and before the seroconversion. Data regarding antibody levels
before and after SGS seroconversion were compared using the Wilcoxon signed rank paired test. The ratios were compared using Kruskal
Wallis Test with Dunn’s multiple comparisons. Median values from the groups SGS and LJM17+11 were not statistically different. In addition,
LJM11 and LJM17 groups were not different but both displayed significantly lower ratios than SGS group (p,0.0001 for both comparisons).
***p,0.0001.
doi:10.1371/journal.pntd.0000649.g002
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The statistical analyzes were performed using the GraphPad
prism software 5.0 (GraphPad Prism Inc., San Diego, CA). Data
regarding antibody levels before and after SGS seroconversion
were compared using the Wilcoxon signed rank paired test.
Kruskal Wallis with Dunn’s multiple comparisons test was
performed to estimate differences of OD values between three
or more groups. ROC curves were used to establish the cut-off
values based on the identification of the serology value, which
presented the highest sensitivity and specificity in the prediction
of anti-SGS positivity. Correlations between the antibody titers
against SGS and those against rLJM17 and rLJM11 recombi-
nant proteins were checked using the non-parametric Spearman
test. For the validation of the serology in the third phase of the
study, the calculation of sensitivity, specificity and predictive
values were done through contingence tables. In all instances,
differences presenting p,0.05 were considered statistically
significant.
Figure 3. ROC curves of antibody threshold levels predicting ELISA positivity against SGS. A, ROC curves were built using data regarding
the serum antibody levels (OD) against the different recombinant salivary proteins obtained from 40 individuals seroconverted and 40 who did not
seroconverted according to the cut-off levels described in Figure 1. The filled area represents the increment in the area under the curve from results
obtained using rLJM17+rLJM11 compared with the best test using either antigen alone. Samples were tested in duplicate. B, Detailed information
obteined from each ROC curve is shown, such as area under curves (AUC), p values of the ROC curves, the cut-off values chosen, and sensitivity and
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Figure 4. Assessment of the specificity of the Lu. longipalpis SGS and the recombinant salivary proteins. A, samples from 40 individuals
from an endemic area for Lu. longipalis where tested for serology against the Lu. intermedia SGS. In addition, 40 individuals from an endemic area for
Lu. intermedia were tested for serology against Lu. longipalpis SGS.
doi:10.1371/journal.pntd.0000649.g004
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In the first part of this study, we tested whether rLJM17 and
rLJM11 are associated with Lu. longipalpis exposure we measured
the reactivity of total SGS, rLJM17, rLJM11 using serum samples
from 26 children that seroconverted to SGS-positive in a period of
six months. Figure 2A shows anti-SGS antibody levels at time 0
and 6 months, demonstrating a significant increase in the optical
density of the samples. Using the same serum samples, assays were
then performed with rLJM17, rLJM11 or a combination of both
proteins as antigens. Both rLJM17 and rLJM11 were able to
reflect the SGS-seroconversion in a variable number of samples
(Figure 2B–C).
Combining both proteins considerably increased the detection
of anti-SGS seroconversion, as only four samples were negative
within those positive for anti-SGS (Figure 2D). In addition, in
agreement with these findings, the OD values fold increases were
lower for both anti-rLJM11 and anti-rLJM17 compared with anti-
SGS (Figure 2E). The serology using the combination of the
recombinant proteins displayed a higher fold increase, similar to
the pattern observed for anti-SGS (Figure 2E). Western blot
analysis performed for a small number of sera showed that some
samples that recognize LJM17 do not recognize LJM11 and vice
versa (data not shown; Teixeira et al. unpublished data),
reinforcing the use of combined antigens to enhance sensitivity.
We further evaluated the effectiveness of the recombinant
proteins in predicting anti-SGS seroconversion using a larger
sample of individuals (n=80), in which 40 were negative and 40
were positive for anti-SGS. The combination of both rLJM17 and
rLJM11 as antigens incremented effectiveness by 8% compared to
rLJM17 tested alone and by 17% compared to rLJM11, estimated
by the area under the curves (Figure 3A). Thus, serology using
these two combined salivary antigens is suitable to discriminate
individuals exposed to Lu. longipalpis saliva (AUC: 0.89; p,0.0001;
cut-off 0.054; likelihood ratio: 8.34) compared with the use of
LJM17 (AUC: 0.81; p,0.0001; cut-off: 0.022; likelihood ratio:
5.69) or LJM11 (AUC: 0.72; p=0.035; cut-off: 0.063; likelihood
ratio: 2.16) separately (Figure 3B).
Before SGS or the salivary recombinant proteins could be
validated as markers of exposure to Lu. longipalpis, it was
necessary to assess the specificity by evaluating reactivity towards
individuals exposed to other sand flies. Hence, we tested serum
samples from an endemic area for cutaneous Leishmaniasis
(Canoa, Bahia, Brazil), in which the major species of sand flies is
the Lutzomyia intermedia. Both Lu. longipalpis and Lu. intermedia
normally live in different ecosystems and only rarely individuals
are exposed to both of them. We used data from 40 individuals
exposed to Lu. intermedia in a previous investigation [9] and
addressed the cross-reactivity to the whole SGS or rLJM17 and
rLJM11 from Lu. longipalpis. Furthermore, 40 individuals who lived
in an endemic area for Lu. longipalpis were tested for anti-SGS
from Lu. intermedia serology (Figure 4). Almost all individuals from
the Lu. longipalpis endemic area presented positive serology for this
vector, but none of them were positive for anti-SGS for Lu.
intermedia (Figure 4). Thirty-eight out of 40 individuals from Lu.
intermedia endemic area displayed positive serology for the saliva of
this vector, six also recognized Lu. longipalpis SGS (Figure 4), one
recognized rLJM11, two recognized rLJM17 and the same two
recognized the combination of the two recombinant proteins.
Thus, to the end of the second phase of the study we found that
both SGS and the recombinant salivary proteins present very low
cross-reactivity against a different and wide distributed sand fly. In
addition, we established the combination of the recombinant
proteins as a potential good predictor of exposure to Lu. longipalpis,
since ROC curve analysis showed a sensitivity of 91% and a
specificity of 76% with the cut-off value of 0.054 OD, with a
likelihood ratio of 8.34.
The final step was to validate the use of these salivary antigens
as a reliable marker of exposure to Lu. longipalpis. To do so, we
tested a panel of 1,077 samples of unknown anti-SGS status from
children from another visceral Leishmaniasis endemic area. Sera
positive against rLJM17+rLJM11 displayed a positive correlation
with anti-SGS IgG levels (Spearman r=0.379, p,0.0001;
Figure 5A). Additionally, when considering only individuals who
seroconverted to SGS (n=200), this correlation became stronger
(Spearman r=0.491, p,0.0001; Figure 5B). The overall perfor-
mance of the serology using the combined recombinant proteins
was satisfactory, with a sensitivity of 77% (95% CI: 70.5–82.6), a
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Figure 5. Correlations between antibody production against
the whoke saliva and the combined recombinant proteins
LJM11 and LJM17. A, Antibody levels (OD) were correlated within
1,077 individuals from an endemic area of viceral leishmaniasis. B, The
same correlation was performed in the subgroup of 200 individuals
from the 1,077, who seroconverted for anti-SGS during the follow up.
Data was analyzed using Spearman test. The values of r and p are
plotted in each graph.
doi:10.1371/journal.pntd.0000649.g005
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(95% CI: 92.6–95.9), and a likelihood ratio of 6.43 (Figure 6). We
then stratified SGS positive cases in quartiles according to optical
density values in order to verify if the efficiency of the serology
would increment in those individuals with higher antibody titers
against SGS (Figure 6A). Concordant and discordant results from
the combined rLJM17 and rLJM 11 serology were calculated for
each quartile (Figure 6B). The assay using combined salivary
antigens presented a general trend with increased effectiveness of
prediction in individuals with higher anti-SGS antibody titers
(Figure 6B). Thus, the use of the recombinant salivary proteins was
effective in the estimation of exposure to the Lu. longipalpis saliva
(Figure 6C).
Age could be an important factor influencing exposure in the
endemic areas and thus we tested whether the concentrations of
anti-SGS antibodies were influenced by age. In the age range
included in the study, there was no difference in the age
distribution of positive individuals within stratified quartiles,
(Kruskal Wallis test p=0.065), indicating that the antibody titers
may likely represent exposure to the sand fly.
Discussion
Antibodies against the salivary gland components of blood
sucking insects [11,12], can be used as epidemiological markers of
vector exposure [13], as has been shown for Leishmaniasis [4,5].
Large epidemiological investigations using salivary gland antigens
are hampered by the limitation of obtaining large amounts of
highly reproducible salivary glands sonicate. Herein we report on
the detection of sera reactive to whole SGS using two recombinant
proteins from Lu. longipalpis saliva, rLJM17 and rLJM11 and show
a positive correlation between the results obtained using SGS and
those obtained using rLJM17+rLJM11 as antigens.
Besides the possibility of being produced in large amounts,
recombinant salivary proteins bring another advantage to
serological tests as they can produce in a highly reproducible
fashion. It is known that sand fly saliva protein profile, as well as its
relative content, varies at different stages after a meal [6,14,15],
and this cannot be totally controlled even in standardized colonies.
The combined use of different recombinant proteins is justified
since not all SGS-positive sera recognize the same protein bands
[5]. In the present study, some serum samples recognized either
rLJM17 or rLJM11 when tested by ELISA and this was further
confirmed by western blot (data not shown). Such differential
recognition may explain the better performance of the test when
samples highly reactive to SGS were employed. Other immuno-
genic salivary proteins are likely candidates to be tested in
conjunction with rLJM17 and rLJM11, which may increase the
test sensitivity.
Importantly, recombinant molecules selected for use in serology
should not cross-react with salivary proteins from other non-vector
sand fly species, which may lead to false positive results. In order to
test for specificity, we have evaluated sera from one area where Lu.
longipalpis is highly predominant to one area where this species is
not found. In a large survey in the whole Sa ˜o Luis island, including
the three municipalities which comprise areas 1 and 3 of the




























Total negative for anti-SGS: 877
Negative TN: 772 FP: 105
Q1 TP: 30 FN: 20 Sensitivity: 60%
Q2 TP: 36 FN: 14 Sensitivity: 72%
Q3 TP: 42 FN: 08 Sensitivity: 84%
Q4 TP: 46 FN: 04 Sensitivity: 92%
Stratified performance
LJM17+11
Total positive for anti-SGS: 200





Sensitivity: 77% (95%CI: 70.5-82.6) 
Specificity: 88% (95%CI: 88.7-90.1)
PPV: 60% (95%CI: 53.2-65.5)
NPV: 94.4% (95%CI: 92.6-95.9)
Likelihood ratio: 6.431
Figure 6. Validation of the combination of rLMJ 17 and rLJM 11 for the estimation of human exposure to Lu. longipalpis saliva. A total
of 1,077 individuals from an endemic are of visceral leishmaniasis were tested for anti-SGS and for the combined recombinant proteins (rLJM17 +
rLJM11). A, anti-SGS titers (OD). The antibodies concentrations of the positive samples were gouped into quartiles (Q). B and C, the overall
performance of the serology using the recombinant proteins predicting anti-SGS positivity was estimated, and also the sensitivity of the assay
according to the quartiles in positive samples. TP, true positive; FP, false positive; TN, true negative; FN, false negative; PPV, positive predictive value;
NPV, negative predictive value; CI, confidence interval.
doi:10.1371/journal.pntd.0000649.g006
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(66.4%) of the captured specimens. It was followed by Lutzomyia
whitmani (24%) and Lutzomyia evandroi (5.9%), with the remaining 29
species represented 3.7% of the total sample [16]. On the other
hand, in the Canoa village (area 2 of the present study) a
phlebotomine survey performed at the time of sera collection
evidenced a marked predominance of Lu. intermedia, representing
94% of the captured specimens, with a small number of Lutzomyia
migonei and Lutzomyia (Nyssomyia) sp. [17]. Comparative sequence
analysis of LJM17 from Lu. longipalpis and Lu. intermedia LJM17-
homologue showed some areas of high aminoacid conservancy
(Teixeira et al. unpublished data). However, cross reactivity with
Lu. longipalpis SGS was not observed in animals experimentally
exposed to Lu. intermedia SGS [9]. Likely, the tertiary conformation
of the LJM17 protein from Lu. longipalpis, is distinct from that of
Lu.intermedia accounting for the specificity of the assay.
In conclusion, we have shown here that ELISA employing two
recombinant proteins derived from Lu. longipalpis saliva is a
powerful tool for detecting specific exposure to vector sand flies in
populations. These proteins represent a promising epidemiological
tool that can aid in implementing control measures against
Leishmaniasis.
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